Europe Vitamin K2 Market Size, Share & Trends Analysis Report By Product Type (MK-7 and MK-4), By Form (Powder & Crystalline, Capsules & Tablets, and Oils & Liquid), By Application, By Country and Growth Forecast, 2024 - 2031
Description
Europe Vitamin K2 Market Size, Share & Trends Analysis Report By Product Type (MK-7 and MK-4), By Form (Powder & Crystalline, Capsules & Tablets, and Oils & Liquid), By Application, By Country and Growth Forecast, 2024 - 2031
The Europe Vitamin K2 Market would witness market growth of 12.9% CAGR during the forecast period (2024-2031).
The Germany market dominated the Europe Vitamin K2 Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $17,312.1 Thousands by 2031, growing at a CAGR of 11.6 % during the forecast period. The UK market is expected to witness a CAGR of 12% during (2024 - 2031). Additionally, The France market is expected to witness a CAGR of 13.8% during (2024 - 2031).
Vitamin K2's role in activating proteins that regulate calcium deposition underscores its importance in maintaining optimal health. There is a protein known as osteocalcin that plays a significant role in the process of binding calcium to the bone matrix, which in turn helps to enhance bone mineralization and strength.
Moreover, another protein, matrix Gla-protein (MGP), inhibits calcium from depositing in the arteries, preventing arterial calcification and promoting cardiovascular health. These dual functions of vitamin K2 in bone and cardiovascular health drive its demand as an essential dietary supplement.
Europe has a growing aging population, which is more susceptible to conditions like osteoporosis and cardiovascular disease. Vitamin K2 shows promise in preventing and managing these conditions, making it attractive for this demographic. The Federal Statistical Office of Germany (Destatis) predicts that the number of individuals in Germany who are at least 67 years of age will increase by approximately 4 million to a minimum of 20.0 million by the mid-2030s. The number of people who are 80 years old or older is expected to stay relatively consistent until the middle of the 2030s, with a range of 5.8 to 6.7 million.
Based on Product Type, the market is segmented into MK-7 and MK-4. Based on Form, the market is segmented into Powder & Crystalline, Capsules & Tablets, and Oils & Liquid. Based on Application, the market is segmented into Health Supplements, Pharmaceutical, and Functional Food & Beverages. Based on Source, the market is segmented into Natural and Synthetic. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- Balchem Corporation
- Novozymes A/S (Novo Holdings A/S)
- BASF SE
- Lonza Group Ltd. (Capsugel)
- Haihang Industry Co.,Ltd. (Haihang Group)
- AngelYeast Co., Ltd.
- Kyowa Hakko USA, Inc.
- Lesaffre Group
- DSM Nutritional Products
- Herbalife International, Inc
By Product Type
- MK-7
- MK-4
- Powder & Crystalline
- Capsules & Tablets
- Oils & Liquid
- Health Supplements
- Pharmaceutical
- Functional Food & Beverages
- Natural
- Synthetic
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of Contents
114 Pages
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Vitamin K2 Market, by Product Type
- 1.4.2 Europe Vitamin K2 Market, by Form
- 1.4.3 Europe Vitamin K2 Market, by Application
- 1.4.4 Europe Vitamin K2 Market, by Source
- 1.4.5 Europe Vitamin K2 Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market at a Glance
- 2.1 Key Highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
- 3.3 Porter Five Forces Analysis
- Chapter 4. Europe Vitamin K2 Market by Product Type
- 4.1 Europe MK-7 Market by Country
- 4.2 Europe MK-4 Market by Country
- Chapter 5. Europe Vitamin K2 Market by Form
- 5.1 Europe Powder & Crystalline Market by Country
- 5.2 Europe Capsules & Tablets Market by Country
- 5.3 Europe Oils & Liquid Market by Country
- Chapter 6. Europe Vitamin K2 Market by Application
- 6.1 Europe Health Supplements Market by Country
- 6.2 Europe Pharmaceutical Market by Country
- 6.3 Europe Functional Food & Beverages Market by Country
- Chapter 7. Europe Vitamin K2 Market by Source
- 7.1 Europe Natural Market by Country
- 7.2 Europe Synthetic Market by Country
- Chapter 8. Europe Vitamin K2 Market by Country
- 8.1 Germany Vitamin K2 Market
- 8.1.1 Germany Vitamin K2 Market by Product Type
- 8.1.2 Germany Vitamin K2 Market by Form
- 8.1.3 Germany Vitamin K2 Market by Application
- 8.1.4 Germany Vitamin K2 Market by Source
- 8.2 UK Vitamin K2 Market
- 8.2.1 UK Vitamin K2 Market by Product Type
- 8.2.2 UK Vitamin K2 Market by Form
- 8.2.3 UK Vitamin K2 Market by Application
- 8.2.4 UK Vitamin K2 Market by Source
- 8.3 France Vitamin K2 Market
- 8.3.1 France Vitamin K2 Market by Product Type
- 8.3.2 France Vitamin K2 Market by Form
- 8.3.3 France Vitamin K2 Market by Application
- 8.3.4 France Vitamin K2 Market by Source
- 8.4 Russia Vitamin K2 Market
- 8.4.1 Russia Vitamin K2 Market by Product Type
- 8.4.2 Russia Vitamin K2 Market by Form
- 8.4.3 Russia Vitamin K2 Market by Application
- 8.4.4 Russia Vitamin K2 Market by Source
- 8.5 Spain Vitamin K2 Market
- 8.5.1 Spain Vitamin K2 Market by Product Type
- 8.5.2 Spain Vitamin K2 Market by Form
- 8.5.3 Spain Vitamin K2 Market by Application
- 8.5.4 Spain Vitamin K2 Market by Source
- 8.6 Italy Vitamin K2 Market
- 8.6.1 Italy Vitamin K2 Market by Product Type
- 8.6.2 Italy Vitamin K2 Market by Form
- 8.6.3 Italy Vitamin K2 Market by Application
- 8.6.4 Italy Vitamin K2 Market by Source
- 8.7 Rest of Europe Vitamin K2 Market
- 8.7.1 Rest of Europe Vitamin K2 Market by Product Type
- 8.7.2 Rest of Europe Vitamin K2 Market by Form
- 8.7.3 Rest of Europe Vitamin K2 Market by Application
- 8.7.4 Rest of Europe Vitamin K2 Market by Source
- Chapter 9. Company Profiles
- 9.1 Balchem Corporation
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Regional & Segmental Analysis
- 9.1.4 Research & Development Expenses
- 9.1.5 SWOT Analysis
- 9.2 Novozymes A/S (Novo Holdings A/S)
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Regional Analysis
- 9.2.4 Research & Development Expenses
- 9.3 BASF SE
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expense
- 9.3.5 SWOT Analysis
- 9.4 Lonza Group Ltd. (Capsugel)
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expenses
- 9.4.5 SWOT Analysis
- 9.5 Haihang Industry Co., Ltd. (Haihang Group)
- 9.5.1 Company Overview
- 9.6 AngelYeast Co., Ltd.
- 9.6.1 Company Overview
- 9.6.2 SWOT Analysis
- 9.7 Kyowa Hakko USA, Inc.
- 9.7.1 Company Overview
- 9.8 Lesaffre Group
- 9.8.1 Company Overview
- 9.8.2 SWOT Analysis
- 9.9 Anderson Global Group, LLC
- 9.9.1 Company Overview
- 9.10. Herbalife International, Inc.
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Regional Analysis
- 9.10.4 SWOT Analysis
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
